VKH
TRIL

Virtu KCG Holdings’s Trillium Therapeutics Inc. TRIL Stock Holding History

Virtu KCG Holdings’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$128K Buy
+29,081
New +$161K ﹤0.01% 2348
2017
Q1 		– Sell
-22,470
Closed -$127K – 3962
2016
Q4 		$127K Buy
+22,470
New +$224K ﹤0.01% 2819

Other funds holding TRIL

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Virtu KCG Holdings's TRIL Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Trillium Therapeutics Inc. (TRIL) in Q2 2017: 29,081 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #2348 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in TRIL as recently as Q4 2016.

Virtu KCG Holdings first reported a position in TRIL in Q4 2016 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold TRIL as of Q2 2017.

  • Virtu KCG Holdings held 29,081 shares of Trillium Therapeutics Inc. worth $128K as of Q2 2017.
  • Trillium Therapeutics Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Trillium Therapeutics Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2348 holding.
  • Virtu KCG Holdings first reported a position in Trillium Therapeutics Inc. in Q4 2016 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.